PUBLISHER Wolters Kluwer
Pharma Solutions has announced
that its Adis journal Drugs in R&D
will be available at no charge,
moving from its previous
subscription-based model.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Jun 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jun 10
LEADING pharmacy, consumer and Federal agencies want to see better use of existing funding and leverage digital health resources to improve quality use of medicines, discussions at the Medicines Safety Forum in Canberra revealed.
THOUSANDS of General Practitioners will receive a letter in the coming days from the Department of Health (DoH) aimed at cutting inappropriate prescribing of psychotrophic medicines, the Royal Australian College of General Practitioners’ (RACGP’s) newsGP revealed.